-
New Zealand may join Australia-Fiji defence pact: PM Luxon
-
All Blacks make five changes for Italy Nations Championship clash
-
Fly-half Meredith to make Australia debut against France
-
Western Europe records its hottest June as heatwaves surge: EU monitor
-
US, Iran trade new strikes in fight over Hormuz strait
-
Fashion's mystery man Margiela sells off his archives
-
Modi eyes 'historic' chance to secure Australian uranium
-
Nuclear test-scarred Marshall Islands criticises China missile
-
US crackdown on top AI fuels open-source surge
-
Chip titan SK hynix to set price for mega US listing
-
EU moves closer to kicking kids off social media
-
Crude extends rally as US-Iran flare-up rocks peace hopes
-
Protecting the protectors: racing to save Philippine mangroves
-
Democrat accused of rape exits key US Senate race
-
Expanded World Cup; same old story as Europe dominates quarter-finals
-
Japan student Ito keeps place against Ireland as Jones returns
-
Morocco's Saibari out of France World Cup quarter-final
-
Belgium bid to crack Spain's ironclad defence in World Cup quarter-final
-
Trump orders new strikes on Iran over attacks on shipping in Hormuz
-
US man sentenced after swapping 17th century manuscript
-
PSG's Lee set to join Atletico Madrid
-
US launches new strikes on Iran after Trump vows to hit 'hard'
-
Iran plays with fire, but calculates Trump will hold back
-
Taylor Swift fans pay $25 for garbage from outside wedding
-
Oil surges, stocks slide as Trump says Iran ceasefire over
-
After quakes, Venezuelans fear losing damaged homes
-
Meta to build $9 billion data center in western Canada
-
PSG's Lee set to join Athletico
-
Rogers backs Kane to outshine Haaland in World Cup showdown
-
Erdogan gave pistols to NATO leaders, Starmer says
-
Some US Fed officials considered June rate hike on war fallout
-
Nocera Expands Diversified Technology Strategy With Binding Agreement to Acquire an Equity Interest in INERGX, an Integrated Energy Storage and Power Platform for AI, Defense and Mission-Critical Demand
-
UN launches appeal for nearly $300 mn in Venezuela quake relief
-
China sends nuclear missile message as US looks elsewhere
-
US to remove Syria from terror blacklist, in new boost to Sharaa
-
Justin Bieber added to 11-minute World Cup final halftime show
-
Court rejects Trump request to restore his name to Kennedy Center
-
Fery targets Wimbledon final birthday present after royal seal of approval
-
MLB pitching great Verlander to retire after 2026 season
-
Egypt file complaint against referee after World Cup exit
-
Artificial cloud brightening could tame El Nino, but with risks: study
-
Women's semi-finalists in uncharted territory at Wimbledon
-
Shocked and shaken, Venezuela quake survivors get psychological help
-
US man jailed after swapping 17th century manuscript
-
France, Morocco kick off blockbuster World Cup quarter-finals
-
UN maritime head urges halt to Hormuz transit to protect seafarers
-
Amorim hails 'ambitious' AC Milan, promises to learn Italian
-
Trump skips new Air Force One on return from Turkey NATO summit
-
Cancer survivor Traeen takes the long road to Tour yellow
-
New York building that buckled now 'stable,' says mayor
Adding peanuts to young children's diet can help avoid allergy: study
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Researchers found that introducing peanut products to babies and infants, and gradually increasing exposure, led to greater tolerance for the common allergen.
The peer-reviewed study, published in The Lancet, involved 146 peanut-allergic children aged between zero and three over two-and-a-half years.
Of the group, 96 were given peanut protein powder every day, with the dose increasing progressively to the equivalent of six peanuts. The other children received a placebo of oat flour.
Twenty of the children who received peanut powder showed allergy remission, meaning no allergic reaction occurred six months after the therapy ended.
One child in the placebo group showed remission.
Six months after the treatment, the children in remission could tolerate a dose equivalent to 16 peanuts.
An additional 20 children who received peanut powder were considered 'desensitised', meaning they had a higher allergic threshold but were not considered in remission.
These children could tolerate a dose equivalent to between six and 12 peanuts six months after the treatment ended.
The youngest children in the study experienced remission the most often, and the best results were in those under 12 months.
"Very early interventions may provide the best opportunity to achieve remission", said co-author Stacie Jones.
- 'Considerable burden' -
Peanut allergies affect two percent of children in Western countries, according to the study, and can last a lifetime.
Affected children must avoid eating peanuts and have self-injectable adrenaline available to fight allergic shocks, which can be fatal if they are accidentally exposed.
Exposure can even occur when a child hugs someone who has just consumed peanuts.
"There are no treatment options, resulting in a considerable burden on allergic children and their caregivers to avoid accidental exposure," said co-author Wesley Burks.
"In severe cases, this can restrict peanut-allergic children's freedoms, particularly when it comes to navigating daycare or schools and public spaces where access to a safe diet is in jeopardy," he added.
Previous studies have produced similar results but the length of the latest studies makes it unique.
Although it provided important results, it may not reflect the behaviour of the children's bodies in real-world conditions.
The study was conducted under close medical supervision, and adrenaline injections were administered on 21 children during the trial.
Y.Nakamura--AMWN